BDNF and Parkinson disease: In Alzheimer’s Disease (AD), for instance, reduced BDNF levels are associated with the accumulation of beta-amyloid plaques and tau tangles (22, 23), while in Parkinson’s disease, BDNF stimulation can promote the dopaminergic neuron survival and differentiation in the substantia nigra (24).